Vitamin D3-loaded nanostructured lipid carriers as a potential approach for fortifying food beverages; in vitro and in vivo evaluation

Advanced Pharmaceutical Bulletin

Volumn 7, Issue 1, 2017, Pages 61-71

  Mohammadi, Maryam ^a,b   Pezeshki, Akram ^b,c   Abbasi, Mehran Mesgari ^d   Ghanbarzadeh, Babak ^b   Hamishehkar, Hamed ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Nanoparticle; Nanostructured lipid carriers; NLC; Vitamin D3

Indexed keywords

COLECALCIFEROL; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; LIPID; MIGLYOL; OCTYLOCTANOAT; POLOXAMER; POLYSORBATE 20; POLYSORBATE 80; UNCLASSIFIED DRUG;

AGGLOMERATION; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BEVERAGE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISPERSION; HOT HOMOGENIZATION METHOD; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; LIMIT OF QUANTITATION; MALE; NONHUMAN; PARTICLE SIZE; PHYSICAL PARAMETERS; RAT;

EID: 85017565147     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.15171/apb.2017.008     Document Type: Article

References (36)

1. McClements DJ. Crystals and crystallization in oil-in-water emulsions: Implications for emulsion-based delivery systems. Adv Colloid Interface Sci 2012;174:1-30. doi: 10.1016/j.cis.2012.03.002
2. Tsiaras WG, Weinstock MA. Factors influencing vitamin d status. Acta Derm Venereol 2011;91(2):115-24. doi: 10.2340/00015555-0980
3. Banville C, Vuillemard JC, Lacroix C. Comparison of different methods for fortifying cheddar cheese with vitamin D. Int Dairy J 2000;10(5-6):375-82. doi: 10.1016/S0958-6946(00)00054-6
4. Cortesi R, Esposjto E, Luca G, Nastruzzi C. Production of lipospheres as carriers for bioactive compounds. Biomaterials 2002;23(11):2283-94
5. Zuccari G, Carosio R, Fini A, Montaldo PG, Orienti I. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles. J Control Release 2005;103(2):369-80. doi: 10.1016/j.jconrel.2004.12.016
6. Sawant KK, Dodiya SS. Recent advances and patents on solid lipid nanoparticles. Recent Pat Drug Deliv Formul 2008;2(2):120-35
7. Chen CC, Tsai TH, Huang ZR, Fang JY. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm 2010;74(3):474-82. doi: 10.1016/j.ejpb.2009.12.008
8. Weiss J, Decker E, McClements DJ, Kristbergsson K, Helgason T, Awad T. Solid lipid nanoparticles as delivery systems for bioactive food components. Food Biophys 2008;3(2):146-54. doi: 10.1007/s11483-008-9065-8
9. Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001;47(2-3):165-96
10. Yuan H, Wang LL, Du YZ, You J, Hu FQ, Zeng S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf B Biointerfaces 2007;60(2):174-9. doi: 10.1016/j.colsurfb.2007.06.011
11. Tamjidi F, Shahedi M, Varshosaz J, Nasirpour A. Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innov Food Sci Emerg Technol 2013;19(0):29-43. doi: 10.1016/j.ifset.2013.03.002
12. Aditya NP, Ko S. Solid lipid nanoparticles (SLNs): Delivery vehicles for food bioactives. RSC Adv 2015;5(39):30902-11. doi: 10.1039/C4RA17127F
13. Ranpise NS, Korabu SS, Ghodake VN. Second generation lipid nanoparticles (nlc) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf B Biointerfaces 2014;116:81-7. doi: 10.1016/j.colsurfb.2013.12.012
14. Esposito E, Ravani L, Drechsler M, Mariani P, Contado C, Ruokolainen J, et al. Cannabinoid antagonist in nanostructured lipid carriers (nlcs): Design, characterization and in vivo study. Mater Sci Eng C Mater Biol Appl 2015;48:328-36. doi: 10.1016/j.msec.2014.12.012
15. Fathi M, Mozafari MR, Mohebbi M. Nanoencapsulation of food ingredients using lipid based delivery systems. Trends Food Sci Tech 2012;23(1):13-27. doi: 10.1016/j.tifs.2011.08.003
16. Muller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (nlc) in cosmetic dermal products. Adv Drug Deliv Rev 2007;59(6):522-30. doi: 10.1016/j.addr.2007.04.012
17. Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242(1-2):121-8
18. Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, et al. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloids Surf B Biointerfaces 2009;74(1):340-9. doi: 10.1016/j.colsurfb.2009.08.003
19. Seetapan N, Bejrapha P, Srinuanchai W, Ruktanonchai UR. Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (slns). Micron 2010;41(1):51-8. doi: 10.1016/j.micron.2009.08.003
20. Pardeike J, Hommoss A, Muller RH. Lipid nanoparticles (sln, nlc) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366(1-2):170-84. doi: 10.1016/j.ijpharm.2008.10.003
21. Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2003;257(1-2):153-60
22. Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm 2011;409(1-2):260-8. doi: 10.1016/j.ijpharm.2011.02.051
23. Qian C, Decker EA, Xiao H, McClements DJ. Impact of lipid nanoparticle physical state on particle aggregation and β-carotene degradation: Potential limitations of solid lipid nanoparticles. Food Res Int 2013;52(1):342-9. doi: 10.1016/j.foodres.2013.03.035
24. Helgason T, Awad TS, Kristbergsson K, McClements DJ, Weiss J. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (sln). J Colloid Interface Sci 2009;334(1):75-81. doi: 10.1016/j.jcis.2009.03.012
25. Shete H, Patravale V. Long chain lipid based tamoxifen nlc. Part i: Preformulation studies, formulation development and physicochemical characterization. Int J Pharm 2013;454(1):573-83. doi: 10.1016/j.ijpharm.2013.03.034
26. Hung LC, Basri M, Tejo BA, Ismail R, Nang HL, Abu Hassan H, et al. An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives. Colloids Surf B Biointerfaces 2011;87(1):180-6. doi: 10.1016/j.colsurfb.2011.05.019
27. Lim SJ, Kim CK. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002;243(1-2):135-46
28. Kovacevic A, Savic S, Vuleta G, Muller RH, Keck CM. Polyhydroxy surfactants for the formulation of lipid nanoparticles (sln and nlc): Effects on size, physical stability and particle matrix structure. Int J Pharm 2011;406(1-2):163-72. doi: 10.1016/j.ijpharm.2010.12.036
29. Hippalgaonkar K, Majumdar S, Kansara V. Injectable lipid emulsions-advancements, opportunities and challenges. AAPS PharmSciTech 2010;11(4):1526-40. doi: 10.1208/s12249-010-9526-5
30. Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm 2010;401(1-2):93-102. doi: 10.1016/j.ijpharm.2010.09.007
31. Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (nlcs) better than solid lipid nanoparticles (slns): Development, characterizations and comparative evaluations of clotrimazole-loaded slns and nlcs? Eur J Pharm Sci 2012;47(1):139-51. doi: 10.1016/j.ejps.2012.05.010
32. Blum M, Dallal GE, Dawson-Hughes B. Body size and serum 25 hydroxy vitamin d response to oral supplements in healthy older adults. J Am Coll Nutr 2008;27(2):274-9
33. Coelho IM, Andrade LD, Saldanha L, Diniz ET, Griz L, Bandeira F. Bioavailability of vitamin d3 in non-oily capsules: The role of formulated compounds and implications for intermittent replacement. Arq Bras Endocrinol Metabol 2010;54(2):239-43
34. Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm 2007;345(1-2):9-25. doi: 10.1016/j.ijpharm.2007.08.057
35. Pandey R, Ahmad Z, Sharma S, Khuller GK. Nano-encapsulation of azole antifungals: Potential applications to improve oral drug delivery. Int J Pharm 2005;301(1-2):268-76. doi: 10.1016/j.ijpharm.2005.05.027
36. Kakran M, Sahoo NG, Li L. Dissolution enhancement of quercetin through nanofabrication, complexation, and solid dispersion. Colloids Surf B Biointerfaces 2011;88(1):121-30. doi: 10.1016/j.colsurfb.2011.06.020